Cellectar Biosciences - 20 Year Stock Price History | CLRB
- The all-time high Cellectar Biosciences stock closing price was 1000000.00 on June 14, 2005.
- The Cellectar Biosciences 52-week high stock price is 3.51, which is 1110.3% above the current share price.
- The Cellectar Biosciences 52-week low stock price is 0.22, which is 24.1% below the current share price.
- The average Cellectar Biosciences stock price for the last 52 weeks is 1.62.
Cellectar Biosciences Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 0.2974 | 0.3249 | 0.3902 | 0.2406 | 0.2902 | -2.94% |
2024 | 2.6236 | 2.8600 | 4.2400 | 0.2350 | 0.2990 | -89.21% |
2023 | 1.9208 | 1.6300 | 2.9100 | 1.3500 | 2.7700 | 61.99% |
2022 | 4.3403 | 7.0990 | 7.8000 | 1.2700 | 1.7100 | -74.25% |
2021 | 13.0324 | 20.7000 | 25.0000 | 6.1100 | 6.6400 | -68.08% |
2020 | 16.1534 | 24.9000 | 31.7000 | 10.3000 | 20.8000 | -7.56% |
2019 | 20.5260 | 15.8000 | 28.5000 | 10.6000 | 22.5000 | 45.16% |
2018 | 70.8377 | 137.0000 | 137.0000 | 12.9000 | 15.5000 | -88.69% |
2017 | 172.6918 | 128.0000 | 266.0000 | 112.0000 | 137.0000 | 12.30% |
2016 | 310.3655 | 732.0000 | 761.5000 | 105.0000 | 122.0000 | -83.40% |
2015 | 2507.2771 | 3060.1000 | 3550.0000 | 685.0000 | 735.0000 | -76.21% |
2014 | 5441.8342 | 7600.0000 | 8400.0000 | 1989.5000 | 3090.0000 | -58.24% |
2013 | 9087.7563 | 14800.0000 | 15800.0000 | 6000.0000 | 7400.0000 | -50.00% |
2012 | 19331.6667 | 9000.0000 | 40000.0000 | 8600.0000 | 14800.0000 | 68.18% |
2011 | 44191.8884 | 125460.0000 | 153000.0000 | 7400.0000 | 8800.0000 | -88.90% |
2010 | 430675.6746 | 1000000.0000 | 1000000.0000 | 58140.0000 | 79254.0000 | -92.07% |
2009 | 1000000.0000 | 1000000.0000 | 1000000.0000 | 1000000.0000 | 1000000.0000 | 0.00% |
2008 | 977778.9516 | 1000000.0000 | 1000000.0000 | 673200.0000 | 1000000.0000 | 0.00% |
2007 | 1000000.0000 | 1000000.0000 | 1000000.0000 | 1000000.0000 | 1000000.0000 | 0.00% |
2006 | 1000000.0000 | 1000000.0000 | 1000000.0000 | 1000000.0000 | 1000000.0000 | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.014B | $0.000B |
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
Boston Scientific (BSX) | United States | $140.689B | 37.90 |
Stryker (SYK) | United States | $132.255B | 28.42 |
EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
Medtronic (MDT) | Ireland | $105.938B | 15.47 |
Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
ResMed (RMD) | United States | $31.269B | 24.08 |
Agilent Technologies (A) | United States | $29.217B | 19.30 |
GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
Terumo (TRUMY) | Japan | $28.160B | 0.00 |
Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
Insulet (PODD) | United States | $17.332B | 74.11 |
Baxter (BAX) | United States | $14.818B | 10.66 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
Demant (WILYY) | Denmark | $6.644B | 0.00 |
Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
ICU Medical (ICUI) | United States | $3.400B | 29.07 |
Haemonetics (HAE) | United States | $2.872B | 13.52 |
Envista Holdings (NVST) | United States | $2.614B | 20.80 |
GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
AtriCure (ATRC) | United States | $1.565B | 0.00 |
Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
InMode (INMD) | Israel | $1.038B | 8.67 |
Neogen (NEOG) | United States | $0.953B | 12.19 |
Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
Evolus (EOLS) | United States | $0.686B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
Valneva SE (VALN) | France | $0.552B | 0.00 |
Owens & Minor (OMI) | United States | $0.535B | 4.56 |
CeriBell (CBLL) | United States | $0.532B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
Surmodics (SRDX) | United States | $0.394B | 0.00 |
Omeros (OMER) | United States | $0.394B | 0.00 |
SNDL (SNDL) | Canada | $0.368B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
ZimVie (ZIMV) | United States | $0.261B | 15.65 |
Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
Cerus (CERS) | United States | $0.242B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
Quanterix (QTRX) | United States | $0.200B | 0.00 |
Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
High Tide (HITI) | Canada | $0.187B | 0.00 |
Biote (BTMD) | United States | $0.181B | 4.12 |
TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
Brainsway (BWAY) | Israel | $0.155B | 48.47 |
Jin Medical (ZJYL) | China | $0.147B | 0.00 |
Organigram Global (OGI) | Canada | $0.135B | 0.00 |
FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
Agape ATP (ATPC) | $0.094B | 0.00 | |
Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
Exagen (XGN) | United States | $0.080B | 0.00 |
MacroGenics (MGNX) | United States | $0.079B | 0.00 |
Veru (VERU) | United States | $0.078B | 0.00 |
Fonar (FONR) | United States | $0.076B | 10.65 |
Zynex (ZYXI) | United States | $0.066B | 24.22 |
United Health Products (UEEC) | United States | $0.065B | 0.00 |
Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
InterCure (INCR) | Israel | $0.063B | 0.00 |
ImmuCell (ICCC) | United States | $0.049B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 11.61 |
Apyx Medical (APYX) | United States | $0.037B | 0.00 |
Modular Medical (MODD) | United States | $0.036B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
Safety Shot (SHOT) | United States | $0.033B | 0.00 |
Nephros (NEPH) | United States | $0.021B | 0.00 |
INLIF (INLF) | $0.018B | 0.00 | |
Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
Flora Growth (FLGC) | United States | $0.010B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |